Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

ACK1/TNK2 tyrosine kinase: An emerging target for cancer therapeutics

DOI: 10.1158/AACR.EDB-14-6109
Publisher: aacr_education_book - aacr_education_book
Apr 4, 2014